Posts by Raymond J. March
Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Agribusiness and Applied Economics at North Dakota State University.
Are More Vaping Bans Coming Soon? Let’s Hope Not!


Over the past year, the Food and Drug Administration has seemed determined to “wipe out the entire vaping industry.” As former FDA Commissioner Scott Gottlieb, who spearheaded much of the current anti-vaping movement,” notes: “the FDA is so concerned about the dangerous effects of e-cigarettes on American youth that the products may have to...
Read More »

Will FDA Approve Biogen’s Promising New Treatment for Alzheimer’s?


We’re only a few weeks into the new year, and the Food and Drug Administration will soon make a decision that will affect pharmaceutical regulation for decades. Last year, after failing an FDA-required futility test, Biogen abandoned its efforts to develop an Alzheimer’s treatment named aducanumab. However, after conducting an analysis using an expanded...
Read More »

Only Markets Can Alleviate Drug Shortages


The American Heart Association finds that over 1 million heart attacks occur in the United States every year. Fourteen percent of all heart attacks are fatal. Many heart attacks and other cardiovascular issues result from heart disease, which is even more common (and often more deadly). When a heart attack happens, victims need immediate...
Read More »

New FDA Commissioner, Same FDA Problem


President Trump has nominated (and fired) numerous individuals to governmental positions while in office. Arguably, his most popular nominee was Food and Drug Administration Commissioner Scott Gottlieb. As a Modern Healthcare article notes, “Dr. Scott Gottlieb accomplished a rare feat during his two-year tenure as head of the Food and Drug Administration—he earned praise...
Read More »

Telemedicine Continues to Reach New Heights


Imagine you suddenly became injured and needed medical help quickly. How long would it take you to see a physician? For an increasing number of Americans, the answer may be concerning. According to a recent survey of 15 major metropolitan areas, wait times to see a physician for new patients increased by about 30...
Read More »

Breakthrough Alzheimer’s Drug Puts FDA’s Drug-Approval Process into Question


After many successful years as a corporate manager, Roger retired in his late sixties to spend more time with family. Three years into retirement, his once energetic and outgoing demeanor deteriorated, and he no longer found interest in things he once enjoyed. Concerned, his physician referred him to a psychiatrist. During his evaluation, Roger...
Read More »

Is Right-to-Try Legislation a Bust? Time for a Second Opinion.


In 2001, twenty-one-year-old Abigail Burroughs was dying of cancer. After all conventional treatment methods failed to improve her condition, Abigail’s oncologist pleaded with the Food and Drug Administration to allow her to try Erbitux. At the time, Erbitux had not fully passed the FDA’s drug approval process. Abigail was denied access and lost her...
Read More »

Trust Walmart’s Insulin to Save Lives


By making life-saving medication widely available and affordable, retailers like Walmart have undoubtedly saved lives and provided financial relieve for numerous patients in dire situations.

FDA Investigates Supposed Link Between Vaping and Seizures


Although the FDA acknowledges it has yet to find a causal relationship between vaping and seizures, it may continue and strengthen its “historic crackdown” of the vaping industry.

How Government Prolonged the Lobotomy


The use of the lobotomy in US medical history is a shocking and concerning event which continues to leave many asking how such a thing could happen.

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org